Reaction Details Report a problem with these data
Target
D(3) dopamine receptor
Ligand
BDBM593764
Substrate
n/a
Meas. Tech.
Binding Inhibition for Dopamine D3 Receptor
Ki
0.058±n/a nM
Citation
 Tobinaga, H; Masuda, K Condensed ring compounds having dopamine D3 receptor antagonistic effect US Patent  US11578084 Publication Date 2/14/2023 
Target
Name:
D(3) dopamine receptor
Synonyms:
DRD3 | DRD3_HUMAN | Dopamine D3 receptor
Type:
PROTEIN
Mol. Mass.:
44213.40
Organism:
Homo sapiens
Description:
ChEMBL_105671
Residue:
400
Sequence:
MASLSQLSGHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC
  
Inhibitor
Name:
BDBM593764
Synonyms:
US11578084, Compound I-047
Type:
Small organic molecule
Emp. Form.:
C28H35F2N5O3S
Mol. Mass.:
559.671
SMILES:
COC(CN1CCc2sc(OCC(C)(F)F)nc2C1)C1CC2(CC(C2)NC(=O)c2cccc3nn(C)cc23)C1 |(1.42,-3.91,;-.07,-3.51,;-.47,-2.03,;-1.96,-1.63,;-3.05,-2.72,;-2.57,-4.18,;-3.6,-5.33,;-5.11,-5.01,;-6.35,-5.91,;-7.6,-5.01,;-8.93,-5.78,;-10.02,-4.69,;-11.51,-5.09,;-12.6,-4,;-11.11,-6.57,;-12.6,-6.18,;-7.12,-3.54,;-5.58,-3.54,;-4.55,-2.4,;.62,-.94,;.62,.6,;2.16,.6,;3.7,.6,;3.7,2.14,;2.16,2.14,;4.79,3.23,;6.27,2.83,;6.67,1.34,;7.36,3.92,;6.74,5.33,;7.64,6.57,;9.17,6.41,;9.8,5.01,;11.27,4.53,;11.27,2.99,;12.6,2.22,;9.8,2.51,;8.9,3.76,;2.16,-.94,)|
Structure:
Search PDB for entries with ligand similarity: